The 15 analysts offering 1 year price forecasts for TXG have a max estimate of — and a min estimate of —.
Analyst rating
Based on 20 analysts giving stock ratings to TXG in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
TXG EPS for the last quarter is −0.30 USD despite the estimation of −0.33 USD. In the next quarter EPS is expected to reach −0.31 USD. Track more of 10x Genomics, Inc. financials and stay on top of what is up with the company.
In the next quarter 10x Genomics, Inc. revenue is expected to reach 153.44 M USD. Check out 10x Genomics, Inc. revenue and earnings and make informed decisions.
According to analysts, TXG price target is 20.20 USD with a max estimate of 30.00 USD and a min estimate of 14.00 USD. Check if this forecast comes true in a year, meanwhile watch 10x Genomics, Inc. stock price chart and keep track of the current situation with TXG news and stock market news.
We've gathered opinions of 20 analysts rating TXG stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.